Natural ingredients distributor Swisseutic has entered into a partnership with licorice derivate manufacturer, Qinghai Lake Pharmaceutical.
Founded in 1987, Qinghai is one of the most established manufacturers of licorice derivatives worldwide — specialising in the manufacture of Ammonium Glycyrrhizinate (MAG), Dipotassium Glycyrrhizinate, Enoxolone (Glycyrrhetinic Acid), Glycyrrhizic Acid and purified licorice extracts such as Glabridin and Licochalcone A.
Many of these ingredients are used as food flavourings, pharmaceutical excipients and cosmetic ingredients.
Lugano, Switzerland based Swisseutic will now be responsible for the distribution of Qinghai's range of premium licorice derivates within the European market.
"This partnership aligns perfectly with out mission, which is to select and supply high quality natural ingredients capable of meeting the most rigorous quality standards," noted Christian Artaria, Founder and President of Swisseutic.
"Through this partnership, we will support our European clientele across a wide range of sectors, including pharmaceuticals, nutraceuticals, cosmetics and food."
By combining Qinghai Lake Pharmaceutical's expertise in licorice derivative manufacturing with Swisseutics, robust distribution network, the pair plan to unlock the food's potential.
According to Swisseutic, Qinghai's ingredients will be marketed to players across the nutraceutical, pharmaceutical, food and cosmetic industries throughout Europe.